SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures. 1994

A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
Institut National de la Santé et de la Recherche Médicale, Unité 339, Hôpital Saint Antoine, Paris, France.

In rat striatal slices, the increase (114 +/- 11%) in K(+)-evoked [3H]dopamine release induced by neurotensin (10 nM) was antagonized by 2-[(1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl) carboxylamino]tricyclo(3.3.1.1.3.7)decan-2-carboxylic acid (SR 48692, IC50 = 1.2 +/- 0.11 nM). SR 48692 (100 nM) also suppressed the neurotensin (10 nM)-induced increase (47%) in K(+)-evoked [3H]dopamine release in primary cultures of fetal rat mesencephalic cells. These results further characterize SR 48692 as a potent antagonist of neurotensin receptors in the rat.

UI MeSH Term Description Entries
D008297 Male Males
D008636 Mesencephalon The middle of the three primitive cerebral vesicles of the embryonic brain. Without further subdivision, midbrain develops into a short, constricted portion connecting the PONS and the DIENCEPHALON. Midbrain contains two major parts, the dorsal TECTUM MESENCEPHALI and the ventral TEGMENTUM MESENCEPHALI, housing components of auditory, visual, and other sensorimoter systems. Midbrain,Mesencephalons,Midbrains
D009496 Neurotensin A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011804 Quinolines
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
April 2001, Neuroscience letters,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
September 1983, Brain research,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
September 1983, European journal of pharmacology,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
December 1983, The Journal of pharmacy and pharmacology,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
January 1998, Journal of neural transmission (Vienna, Austria : 1996),
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
July 1995, Neuropeptides,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
September 1986, Research communications in chemical pathology and pharmacology,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
February 1997, European journal of pharmacology,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
April 1983, Research communications in chemical pathology and pharmacology,
A Brouard, and M Heaulme, and R Leyris, and D Pelaprat, and D Gully, and P Kitabgi, and G Le Fur, and W Rostene
August 1996, Brain research,
Copied contents to your clipboard!